New York, NY – July 14, 2025,PR Newswire Policy Public Interest
Sun Pharma Announces Launch of LEQSELVI™ (deuruxolitinib) in the United States for the Treatment of Severe Alopecia Areata New York, NY – July 14, 2025 – Sun Pharmaceutical Industries Ltd. (NYSE: SUNP) is pleased to announce the U.S. launch of LEQSELVI™ (deuruxolitinib), a significant advancement in the treatment of severe alopecia areata. This innovative oral … Read more